Comparison of the Predictability of Dentoalveolar Expansion With Two Clear Aligner Systems
1 other identifier
interventional
60
1 country
1
Brief Summary
To analyze the clinical predictability of transverse arch expansion achieved with two clear aligner systems (Invisalign, Angel Aligner-Angel Aligner Pro) by comparing planned and achieved dental movements through digital model analysis at different treatment stages using a repeatable and reproducible digital measurement technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2025
CompletedFirst Submitted
Initial submission to the registry
May 13, 2026
CompletedFirst Posted
Study publicly available on registry
May 27, 2026
CompletedMay 27, 2026
May 1, 2026
Same day
May 13, 2026
May 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dentoalveolar expansion
Change from baseline in maxillary intermolar width measured in millimeters.
One year
Study Arms (3)
Invisalign
EXPERIMENTALThe Invisalign group consisted of 20 patients treated with Invisalign clear aligners, with each aligner worn for 10 days before progressing to the next stage in the treatment sequence.
Angel aligner
EXPERIMENTALThe Angel Aligner group consisted of 20 patients treated with Angel Aligner clear aligners, with each aligner worn for 10 days before progressing to the next stage in the treatment sequence.
Angel Aligner pro
EXPERIMENTALThe Angel Aligner Pro group consisted of 20 patients treated with Angel Aligner clear aligners. Each treatment stage included two aligners: an initial softer aligner worn for 7 days, followed by a second, more rigid aligner worn for 3 days before progressing to the next stage in the treatment sequence.
Interventions
Transverse dentoalveolar expansion was performed according to the virtual treatment planning established in the aligner software. Orthodontic movements were progressively achieved through the sequential use of the planned clear aligner (an aligner per step).
Transverse dentoalveolar expansion was performed according to the virtual treatment planning established in the aligner software. Orthodontic movements were progressively achieved through the sequential use of the planned clear aligners (an aligner per step).
Transverse dentoalveolar expansion was performed according to the virtual treatment planning established in the aligner software. Orthodontic movements were progressively achieved through the sequential use of the planned clear aligners (an initial softer aligner worn for 7 days, followed by a second, more rigid aligner worn for 3 days before progressing to the next stage in the treatment sequence)
Eligibility Criteria
You may qualify if:
- Adult patients with a full permanent dentition
- Absence of auxiliary orthodontic appliances
- A clinical indication for transverse expansion in both dental arches
- Complete diagnostic and treatment records
- Treatment plans involving a minimum of 15 aligners before any refinement phase
- Confirmed adequate compliance with aligner wear (20-22 hours per day)
- patients with skeletal Class I or mild skeletal Class II or III relationships (ANB angle ranging from 0° to 4°
You may not qualify if:
- Severe dental crowding (tooth size-arch length discrepancy exceeding -5 mm)
- Active periodontal pathology
- Treatment plans involving dental extractions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Salamanca
Salamanca, Salamanca, 37008, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 13, 2026
First Posted
May 27, 2026
Study Start
February 13, 2024
Primary Completion
February 13, 2024
Study Completion
September 19, 2025
Last Updated
May 27, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share